Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Clinical trial NCT01798004 · COMPLETED

Trial details

NCT number: NCT01798004
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ganglioneuroblastoma Stage 1 Neuroblastoma Stage 2 Neuroblastoma Stage 2A Neuroblastoma Stage 2B Neuroblastoma Stage 3 Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma

Start date: 2013-04-09
Primary completion: 2015-07-28
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.